Colquhounia root tablet in the treatment of idiopathic membranous nephropathy with subnephrotic proteinuria.

[1]  Ying-yong Zhao,et al.  Membranous nephropathy: Systems biology-based novel mechanism and traditional Chinese medicine therapy , 2022, Frontiers in Pharmacology.

[2]  Xia Li,et al.  Recent Advances in Clinical Diagnosis and Pharmacotherapy Options of Membranous Nephropathy , 2022, Frontiers in Pharmacology.

[3]  Yudong Liu,et al.  Repurposing a clinically approved prescription Colquhounia root tablet to treat diabetic kidney disease via suppressing PI3K/AKT/NF-kB activation , 2022, Chinese Medicine.

[4]  Xiaomei Zhang,et al.  Tripterygium hypoglaucum (Lévl.) Hutch and Its Main Bioactive Components: Recent Advances in Pharmacological Activity, Pharmacokinetics and Potential Toxicity , 2021, Frontiers in Pharmacology.

[5]  B. Rovin,et al.  Executive summary of the KDIGO 2021 Guideline for the Management of Glomerular Diseases. , 2021, Kidney international.

[6]  Rui Lang,et al.  Traditional Chinese Medicine in Treating IgA Nephropathy: From Basic Science to Clinical Research , 2021, Journal of Translational Internal Medicine.

[7]  L. Beck,et al.  Membranous Nephropathy: Core Curriculum 2021. , 2021, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[8]  Wenbin Liu,et al.  How Does Herbal Medicine Treat Idiopathic Membranous Nephropathy? , 2020, Frontiers in Pharmacology.

[9]  V. Jha,et al.  Membranous nephropathy , 2020, Nature Reviews Disease Primers.

[10]  Liangping Jiang,et al.  The genus Tripterygium: A phytochemistry and pharmacological review. , 2019, Fitoterapia.

[11]  G. Cai,et al.  Retrospective analysis of tacrolimus combined with Tripterygium wilfordii polyglycoside for treating idiopathic membranous nephropathy , 2018, BMC Nephrology.

[12]  A. Bomback,et al.  Membranous Nephropathy: Approaches to Treatment , 2018, American Journal of Nephrology.

[13]  Rumeng Li,et al.  Tripterygium wilfordii Glycosides Upregulate the New Anti-Inflammatory Cytokine IL-37 through ERK1/2 and p38 MAPK Signal Pathways , 2017, Evidence-based complementary and alternative medicine : eCAM.

[14]  Feng Xu,et al.  Changes in the Spectrum of Kidney Diseases: An Analysis of 40,759 Biopsy-Proven Cases from 2003 to 2014 in China , 2017, Kidney Diseases.

[15]  D. Cattran,et al.  Membranous nephropathy: integrating basic science into improved clinical management. , 2017, Kidney international.

[16]  Youhua Liu,et al.  Renal fibrosis in 2015: Understanding the mechanisms of kidney fibrosis , 2016, Nature Reviews Nephrology.

[17]  Shanshan Liu,et al.  Comparison of tripterygium wilfordii multiglycosides and tacrolimus in the treatment of idiopathic membranous nephropathy: a prospective cohort study , 2015, BMC Nephrology.

[18]  U. Panzer,et al.  PLA2R Antibody Levels and Clinical Outcome in Patients with Membranous Nephropathy and Non-Nephrotic Range Proteinuria under Treatment with Inhibitors of the Renin-Angiotensin System , 2014, PloS one.

[19]  J. Coresh,et al.  GFR estimation: from physiology to public health. , 2014, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[20]  N. Chen,et al.  Efficacy and safety of traditional chinese medicine (Shenqi particle) for patients with idiopathic membranous nephropathy: a multicenter randomized controlled clinical trial. , 2013, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[21]  M. Jardine,et al.  Tripterygium preparations for the treatment of CKD: a systematic review and meta-analysis. , 2013, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[22]  J. He,et al.  Therapeutic use of traditional Chinese herbal medications for chronic kidney diseases , 2013, Kidney international.

[23]  C. Zeng,et al.  Triptolide reduces proteinuria in experimental membranous nephropathy and protects against C5b-9-induced podocyte injury in vitro. , 2010, Kidney international.

[24]  Taixiang Wu,et al.  Chinese herbal medicine Tripterygium hypoglaucum Hutch tablet for facial corticosteroid addiction dermatitis. , 2008, Journal of alternative and complementary medicine.